08-31-2023
DKK/share | |
Price | 298.50 |
Dividend | 6.00 |
Earnings | 15.00 |
Cash-flow | 14.85 |
Book value | 51.47 |
Equity | 47.47 |
Novozymes A/S is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Novozymes A/S is a company from Denmark, and his stocks are publicly traded.
Novozymes A/S stock dividend
Novozymes A/S paid a total dividend of 1,338 million DKK last year, for a market value of 66,566 millions (Market Cap 59,484 millions). Novozymes A/S dividend per share is 6.00 DKK, and his stock market price 298.50 DKK.
According to the chart below, where dividend yield is displayed, Novozymes A/S has a dividend yield of 2.01%, which is lower than the amount offered by the market average , but bigger than Health Care industry. Dividend yields are similar among companies from the same industry, so it is a positive sign for the company.
In addition, you should compare Novozymes A/S stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the highest Denmark dividend stocks list.
Novozymes A/S Dividend Payout
About the ability of Novozymes A/S to maintain his current dividend of DKK 6.00 per share, an amount that accounts for 2.01%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Novozymes A/S payout on ernings is currently 40.00%, which is higher than the market average, and companies of Health Care industry, which are 39.34% and 23.54% respectively. Both figures show that Novozymes A/S can have problems to keep with his present dividend yield.
The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Novozymes A/S is DKK 14.85 per share, which is higher than the dividend per share paid by the company of DKK 6.00, so the company generates enough cash to maintain his dividend in the future.
The following figure shows payout ratios over earnings and cashflow of Novozymes A/S, compared againt world market average, Denmark companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.
Novozymes A/S Dividend History
Below you will find a table with the historical evolution of Novozymes A/S's dividend stock, both in percentage and in DKK, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).
Year | Yield | DKK | Paypout | Shares* |
Present | 2.01% | 6.00 | 40.00% | 223 |
2022 | 1.56% | 5.49 | 42.26% | 222 |
2021 | 0.98% | 5.26 | 45.42% | 222 |
2020 | 1.50% | 5.24 | 42.88% | 228 |
2019 | 1.53% | 4.99 | 40.24% | 234 |
2018 | 1.55% | 4.51 | 36.76% | 230 |
2017 | 1.13% | 4.01 | 34.96% | 240 |
2016 | 1.47% | 3.50 | 33.72% | 247 |
2015 | 0.88% | 2.99 | 32.75% | 252 |
*In millions
Then you can see the evolution of Novozymes A/S dividend stock, and compare it with the average of Denmark stocks and that of the Pharmaceuticals and Biotechnology stocks.
Novozymes A/S Stock performance
Finally, last moth Novozymes A/S showed a return of -12.20% compared to a worldwide -2.49% average, and a -2.07% of Health Care firms. Over the last year, the company obtained a -29.90% versus a worldwide performance of a 8.71%. More detailed information can be seen in the following graph for Denmark and Pharmaceuticals and Biotechnology firms.